Sunflower seed is one of the most common edible seeds and its
consumption is growing worldwide. Case reports of sunflower seed allergy
have been described in the medical literature since the 1970s. However,
there are few data on the overall prevalence and clinical manifestations
of sunflower seed allergy. We evaluated the clinical and immunological
features of 47 patients with sunflower seed allergy diagnosed in the
Allergy Department of a tertiary hospital in Madrid over a 5-years
period. All of them reported adverse reactions after ingestion of
sunflower and had specific sensitization to sunflower seed determined by
skin prick test (median 7mm) or specific IgE (median 1.07KU/L). Most had
an adult-onset reaction to sunflower seed preceded by a history of atopy
and other food allergies diagnosis, predominantly to peach, peanut and
nuts. Clinical presentation of sunflower seed allergy in our sample
ranged from mild to severe, with a high proportion of patients suffering
severe reactions, often undertreated. A variability in the severity of
symptoms was seen on repeated exposures to sunflower seed on a same
patient. Levels of sunflower seed IgE were strongly correlated with
levels of IgE to non specific lipid transfer proteins, while no
significant differences were found in the severity of the reactions
according sensitization to those proteins. With sunflower seed as a
potential severe allergen, further study on the allergenic content and
clinical cross reactivity of sunflower seed allergy is required in order
to prevent life threatening reactions.